DBV eyes European expansion with Bioprojet deal
This article was originally published in Clinica
Epicutaneous diagnostics specialist DBV Technologies has signed a distribution deal for its Diallertest cow’s milk allergy test with Bioprojet pharma, a drug company specialising in paediatrics. The deal will see Bioprojet promote and distribute the test in France and perhaps beyond: Bioprojet CEO Jeanne-Marie Lecomte said that the firm was “looking forward to working with DBV to make Diallertest Milk more widely available throughout Europe”. Financial terms of the agreement were not revealed. Paris, France-based DBV said that it is currently working on further developing the Diallertest line to include diagnosis tools for wheat, soya and dustmite allergies in children.
You may also be interested in...
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals